Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 30,418Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Allergan Aesthetics

02 3Breckenridge Pharmaceutical

03 3Alembic Pharmaceuticals Limited

04 3Hisamitsu Pharmaceutical Co., Inc.

05 2Kwality Pharmaceuticals

06 2N.V. Organon Kloosterstraat -

07 2ORGANON CANADA INC.

08 8Organon

09 2Sigmapharm Laboratories, LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : SAPHRIS

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2009-08-13

Application Number : 22117

Regulatory Info : RX

Registration Country : USA

Abbvie CB

02

arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : ASENAPINE MALEATE

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 2.5MG BASE

Packaging :

Approval Date : 2020-12-10

Application Number : 205960

Regulatory Info : RX

Registration Country : USA

Breckenridge Pharmaceutical

03

arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : SAPHRIS

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2009-08-13

Application Number : 22117

Regulatory Info : RX

Registration Country : USA

Abbvie CB

04

arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : SAPHRIS

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 2.5MG BASE

Packaging :

Approval Date : 2015-03-12

Application Number : 22117

Regulatory Info : RX

Registration Country : USA

Abbvie CB

05

arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : ASENAPINE MALEATE

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2020-12-10

Application Number : 205960

Regulatory Info : RX

Registration Country : USA

Breckenridge Pharmaceutical

06

arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : ASENAPINE MALEATE

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2021-03-08

Application Number : 205960

Regulatory Info : RX

Registration Country : USA

Breckenridge Pharmaceutical

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : ASENAPINE MALEATE

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2020-12-10

Application Number : 206098

Regulatory Info : RX

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : ASENAPINE MALEATE

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2020-12-10

Application Number : 206098

Regulatory Info : RX

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : ASENAPINE MALEATE

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 2.5MG BASE

Packaging :

Approval Date : 2021-07-19

Application Number : 206098

Regulatory Info : RX

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ASENAPINE

Brand Name : SECUADO

Dosage Form : SYSTEM;TRANSDERMAL

Dosage Strength : 3.8MG/24HR

Packaging :

Approval Date : 2019-10-11

Application Number : 212268

Regulatory Info : RX

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ASENAPINE

Brand Name : SECUADO

Dosage Form : SYSTEM;TRANSDERMAL

Dosage Strength : 5.7MG/24HR

Packaging :

Approval Date : 2019-10-11

Application Number : 212268

Regulatory Info : RX

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ASENAPINE

Brand Name : SECUADO

Dosage Form : SYSTEM;TRANSDERMAL

Dosage Strength : 7.6MG/24HR

Packaging :

Approval Date : 2019-10-11

Application Number : 212268

Regulatory Info : RX

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

asenapinmaleat

Brand Name : Sycrest

Dosage Form : SUBLINGUAL TABLET

Dosage Strength : 10 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

asenapinmaleat

Brand Name : Sycrest

Dosage Form : SUBLINGUAL TABLET

Dosage Strength : 5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Asenapine

Brand Name : Sycrest

Dosage Form : Asenapina 10Mg 60 Units Sublingual Use

Dosage Strength : 60 sublingual cpr 10 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Asenapine

Brand Name : Sycrest

Dosage Form : Asenapina 5Mg 60 Units Sublingual Use

Dosage Strength : 60 sublingual CPR 5 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : ASENAPINE MALEATE

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2020-12-10

Application Number : 206107

Regulatory Info : RX

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ASENAPINE MALEATE

Brand Name : ASENAPINE MALEATE

Dosage Form : TABLET;SUBLINGUAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2020-12-10

Application Number : 206107

Regulatory Info : RX

Registration Country : USA

blank

19

N.V. Organon Kloosterstraat -

Country
2024 ACI Convention
Not Confirmed
arrow

N.V. Organon Kloosterstraat -

Country
arrow
2024 ACI Convention
Not Confirmed

Asenapine

Brand Name : Sycrest

Dosage Form : Sublingvaltablett

Dosage Strength : 10 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

20

N.V. Organon Kloosterstraat -

Country
2024 ACI Convention
Not Confirmed
arrow

N.V. Organon Kloosterstraat -

Country
arrow
2024 ACI Convention
Not Confirmed

Asenapine

Brand Name : Sycrest

Dosage Form : Sublingvaltablett

Dosage Strength : 5 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank